Urological cancer, Malmö
421 – 430 of 499
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.
(
- Contribution to journal › Article
-
Mark
The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids
(
- Contribution to journal › Article
-
Mark
A prospective study on dietary fat and incidence of prostate cancer (Malmö, Sweden).
(
- Contribution to journal › Article
-
Mark
Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells
(
- Contribution to journal › Article
-
Mark
Prostataspecifikt antigen--den viktigaste cancermarkören. Diagnostik och uppföljning av prostatacancer har förändrats markant.
(
- Contribution to journal › Article
-
Mark
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer
(
- Contribution to journal › Article
-
Mark
PSA and Prostate Cancer Screening: The Challenge of the New Millennium.
(
- Contribution to journal › Letter
- 2006
-
Mark
Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.
(
- Contribution to journal › Article
-
Mark
Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C.
(
- Contribution to journal › Article
-
Mark
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration
(
- Contribution to journal › Article